OBJECTIVE: Asthma in children and adolescents is a heterogeneous syndrome comprised of multiple subgroups with variable disease expression and response to environmental exposures. The goal of this study was to define homogeneous phenotypic clusters within a cohort of children and adolescents with asthma and to determine overall and within-cluster associations between environmental tobacco smoke (ETS) exposure and asthma characteristics. METHODS: A combined hierarchical/k-means cluster analysis of principal component variables was used to define phenotypic clusters within a cohort of 6- to 20-year-old urban and largely minority subjects. RESULTS: Among the 154 subjects, phenotypic cluster analysis defined three independent clusters (Cluster 1 [n = 57]; Cluster 2 [n = 33]; Cluster 3 [n = 58]). A small fourth cluster (n = 6) was excluded. Patients in Cluster 1 were predominantly males, with a relative abundance of neutrophils in their nasal washes. Patients in Cluster 2 were predominantly females with high body mass index percentiles and later-onset asthma. Patients in Cluster 3 had higher eosinophil counts in their nasal washes and lower Asthma Control Test (ACT) scores. Within-cluster regression analysis revealed several significant associations between ETS exposure and phenotypic characteristics that were not present in the overall cohort. ETS exposure was associated with a significant increase in nasal wash neutrophils (beta coefficient = 0.73 [95% confidence interval, CI: 0.11 to 1.35]; p = .023) and a significant decrease in ACT score (-5.17 [-8.42 to -1.93]; p = .003) within Cluster 1 and a significant reduction in the bronchodilator-induced % change in forced expiratory volume in one second (FEV(1)) (-36.32 [-62.18 to -10.46]; p = .009) within Cluster 3. CONCLUSIONS: Clustering techniques defined more homogeneous subgroups, allowing for the detection of otherwise undetectable associations between environmental tobacco smoke exposure and asthma characteristics.
OBJECTIVE:Asthma in children and adolescents is a heterogeneous syndrome comprised of multiple subgroups with variable disease expression and response to environmental exposures. The goal of this study was to define homogeneous phenotypic clusters within a cohort of children and adolescents with asthma and to determine overall and within-cluster associations between environmental tobacco smoke (ETS) exposure and asthma characteristics. METHODS: A combined hierarchical/k-means cluster analysis of principal component variables was used to define phenotypic clusters within a cohort of 6- to 20-year-old urban and largely minority subjects. RESULTS: Among the 154 subjects, phenotypic cluster analysis defined three independent clusters (Cluster 1 [n = 57]; Cluster 2 [n = 33]; Cluster 3 [n = 58]). A small fourth cluster (n = 6) was excluded. Patients in Cluster 1 were predominantly males, with a relative abundance of neutrophils in their nasal washes. Patients in Cluster 2 were predominantly females with high body mass index percentiles and later-onset asthma. Patients in Cluster 3 had higher eosinophil counts in their nasal washes and lower Asthma Control Test (ACT) scores. Within-cluster regression analysis revealed several significant associations between ETS exposure and phenotypic characteristics that were not present in the overall cohort. ETS exposure was associated with a significant increase in nasal wash neutrophils (beta coefficient = 0.73 [95% confidence interval, CI: 0.11 to 1.35]; p = .023) and a significant decrease in ACT score (-5.17 [-8.42 to -1.93]; p = .003) within Cluster 1 and a significant reduction in the bronchodilator-induced % change in forced expiratory volume in one second (FEV(1)) (-36.32 [-62.18 to -10.46]; p = .009) within Cluster 3. CONCLUSIONS: Clustering techniques defined more homogeneous subgroups, allowing for the detection of otherwise undetectable associations between environmental tobacco smoke exposure and asthma characteristics.
Authors: J A Castro-Rodríguez; C J Holberg; W J Morgan; A L Wright; F D Martinez Journal: Am J Respir Crit Care Med Date: 2001-05 Impact factor: 21.405
Authors: Thérèse S Lapperre; Jiska B Snoeck-Stroband; Margot M E Gosman; Jan Stolk; Jaap K Sont; Désirée F Jansen; Huib A M Kerstjens; Dirkje S Postma; Peter J Sterk Journal: Am J Respir Crit Care Med Date: 2004-06-01 Impact factor: 21.405
Authors: Stefano Guerra; Anne L Wright; Wayne J Morgan; Duane L Sherrill; Catharine J Holberg; Fernando D Martinez Journal: Am J Respir Crit Care Med Date: 2004-03-17 Impact factor: 21.405
Authors: Angela S Benton; Nikila Kumar; Jennifer Lerner; Andrew A Wiles; Matthew Foerster; Stephen J Teach; Robert J Freishtat Journal: J Investig Med Date: 2010-12 Impact factor: 2.895
Authors: Stephanie L Constant; Robert J Freishtat; Erik J Stemmy; Angela S Benton; Jennifer Lerner; Sarah Alcala Journal: J Asthma Date: 2011-10-14 Impact factor: 2.515
Authors: Sze Man Tse; Diane R Gold; Joanne E Sordillo; Elaine B Hoffman; Matthew W Gillman; Sheryl L Rifas-Shiman; Anne L Fuhlbrigge; Kelan G Tantisira; Scott T Weiss; Augusto A Litonjua Journal: J Allergy Clin Immunol Date: 2013-05-14 Impact factor: 10.793
Authors: Lisa Maltz; Ethan L Matz; Heather Gordish-Dressman; Dinesh K Pillai; Stephen J Teach; Carlos A Camargo; Monica J Hubal; Simran Behniwal; Guy D Prosper; Nicole Certner; Raman Marwah; Douglas M Mansell; Fisayo Nwachukwu; Risa Lazaroff; Yodit Tsegaye; Robert J Freishtat Journal: Pediatr Pulmonol Date: 2016-01-15
Authors: Eduardo Castro-Nallar; Ying Shen; Robert J Freishtat; Marcos Pérez-Losada; Solaiappan Manimaran; Gang Liu; W Evan Johnson; Keith A Crandall Journal: BMC Med Genomics Date: 2015-08-16 Impact factor: 3.063
Authors: Marcos Pérez-Losada; Eduardo Castro-Nallar; Matthew L Bendall; Robert J Freishtat; Keith A Crandall Journal: PLoS One Date: 2015-06-30 Impact factor: 3.240